The global intravenous (IV) equipment market was valued at USD 18,774 million in 2024 and is forecasted to expand at a CAGR of 5.9%, reaching USD 35,270 million by 2035. This growth is driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and heart conditions, which require prolonged intravenous therapy for drug administration, hydration, and nutritional support.
Technological advancements in IV equipment, including smart infusion pumps with wireless connectivity and data analytics, are enhancing safety and efficiency, reducing medical errors, and improving patient outcomes. The market's expansion is also supported by the growing demand for user-friendly, infection-preventing systems in healthcare settings worldwide.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7710
Market Segmentation and Trends:
The intravenous equipment market is segmented by type, end user, and region, providing a detailed analysis of its dynamics. Types include IV catheters, administration sets (solution and blood administration sets), infusion pumps, securement devices and check valves, drip chambers, needleless connectors, and other IV equipment. Infusion pumps and IV catheters dominate due to their critical role in precise medication delivery and vascular access. End users encompass hospitals, ambulatory surgical centers, clinics, and home care settings, with hospitals leading owing to high patient volumes and complex care needs.
Regionally, North America holds the largest share, while Asia Pacific is emerging rapidly due to healthcare infrastructure development. Trends include the adoption of AI-integrated smart pumps for real-time monitoring, eco-friendly disposable equipment to address medical waste, and wireless systems for seamless integration with electronic health records (EHRs).
Comments
0 comment